Marginum
Founded in 2020, Marginum is developing groundbreaking tissue recognition technology, especially for oncological surgery. Marginum technology enables safe and efficient identification of cancerous tissue with minimal damage to healthy tissues.
After seeking out the services of MDS, Marginum have obtained an ISO 13485 certification in 2024, with CE-mark and market entry into the EU well on the way.
